WuXi AppTec Co., Ltd.

Shanghai, Shanghai, China wuxiapptec.com

Overview

WuXi AppTec offers a comprehensive platform of services throughout the pharmaceutical and healthcare industry chain. With its leading capabilities in small molecule drug discovery, development, and manufacturing, as well as cell and gene therapies, the company is a key player in the global life sciences marketplace.

Therapeutic areas

OncologyCardiovascularEndocrinologyInfectious DiseasesNeurology

API / Drug Master Files

WuXi AppTec Co., Ltd. holds 0 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • WUXI ADHERENT HEK293T (WAHT)Inactive2019-01-02
  • LENTIVIRAL VECTORInactive2018-12-28

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to WuXi AppTec Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

Wuxi STA Pharmaceutical Co., Ltd.
China
Metrics Contract Services
United States
QPS Pharma International
USA
Anhui Medical University
China
Convalife Pharmaceuticals Ltd.
China
CSPC Pharmaceutical Group Limited
China
Nanjing Pharmaceutical Factory Co., Ltd.
China
Northeast Pharmaceutical Group Co., Ltd.
China

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo